Presentation TCT 2017 TAVR in Low-Risk Patients Presenter: Jeroen J. Bax, Axel Linke, Thomas Pilgrim October 29, 2017
Presentation TCT 2017 Valve Thrombosis and Durability Presenter: Jeroen J. Bax, Axel Linke, Lars Sondergaard October 29, 2017
Presentation TCT 2017 TAVR vs SAVR: What Do the 2017 ESC Guidelines Say? Presenter: Jeroen J. Bax, Axel Linke, Alec S. Vahanian October 29, 2017
Presentation TCT 2017 Hemodynamics of Aortic Stenosis Presenter: Thomas H. Maloney, Jeff Davis October 29, 2017
News Conference News TCT 2016 Debate Over Low-Risk TAVR Hinges on Definition of Patient Population and Shared Decision-Making Yael L. Maxwell November 02, 2016
News Conference News TCT 2016 Transfemoral—but Not Transthoracic—TAVR Has Early Quality-of-Life Advantage Over Surgery in Intermediate-Risk Patients Todd Neale November 02, 2016
Presentation TCT 2016 TCT 519: Correlation Between Invasive CFR AND Echocardiographic Parameters in Severe Aortic Stenosis Presenter: Alan C. Yeung, Tim P. van de Hoef November 01, 2016
Presentation TCT 2016 TCT 518: The Interaction between Aortic and Coronary Pressures for Fractional Flow Reserve Value in Patients with an Intermediate Coronary Artery Stenosis Presenter: Alan C. Yeung, Tim P. van de Hoef November 01, 2016
Presentation TCT 2016 TCT 517: Fractional Flow Reserve Assessment of Coronary Artery Disease in Patients Undergoing TAVI. Presenter: Alan C. Yeung, Tim P. van de Hoef November 01, 2016
News Conference News TCT 2016 Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence Todd Neale November 01, 2016
Presentation TCT 2016 TCT 516: Instantaneous-wave Free Ratio and Fractional Flow Reserve Comparison in Patients with and Without Severe Aortic Valve Stenosis. Presenter: Alan C. Yeung, Tim P. van de Hoef November 01, 2016
Presentation TCT 2016 FDA Perspectives on TAVR Label Expansion (E.G. Lower Risk Patients, Bicuspid Aortic Stenosis and Aortic Insufficiency), and New and Iterative Device Approval Pathways Presenter: Nicole Ibrahim, Martin B. Leon, Jaime Raben November 01, 2016
Presentation TCT 2016 The Case for Sutureless/ Rapid Deployment Valves Presenter: Michael A. Borger, Vinod H. Thourani November 01, 2016
Presentation TCT 2016 The Case for TAVR Presenter: Michael A. Borger, Vinod H. Thourani, Brian K. Whisenant November 01, 2016
Presentation TCT 2016 Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? No, Given All the Uncertainties About Durability, Valve Thrombus, etc. - Wait for the Data in Low-risk Patients! Presenter: Andreas Baumbach, David Hildick-Smith, Wilson Y. Szeto November 01, 2016
Presentation TCT 2016 Debate - Should TAVR Be Offered to Every Patient With Aortic Stenosis? Yes, Even if Only to Avoid a Disfiguring Sternotomy! Presenter: Andreas Baumbach, David Hildick-Smith, Michael J. Mullen November 01, 2016
News Conference News TCT 2016 TAVR Provides ‘Acceptable’ Outcomes in Low-Flow, Low-Gradient Aortic Stenosis Patients With Poor Ventricular Function Todd Neale November 01, 2016
Presentation TCT 2016 PARTNER I FIVE-YEAR ECHO: Long-term Hemodynamic and Structural Outcomes After Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, Pamela S. Douglas November 01, 2016
News Industry News TCT 2016 Patients With Sever Aortic Stenosis And Intermediate Surgical Risk Show Similar Late Quality of Life Outcomes Following Either Transcatheter or Surgical Aortic Valve Replacement November 01, 2016
Presentation TCT 2016 PARTNER II QUALITY OF LIFE: Health Status Benefits From a Prospective, Randomized Trial of Transcatheter and Surgical Aortic Valve Replacement in Intermediate-Risk Patients With Severe Aortic Stenosis Presenter: Gregg W. Stone, Philippe Pibarot, David J. Cohen November 01, 2016